Comorbidity Patterns in Chronic Obstructive Pulmonary Disease and Their Associations with Service Utilization.

IF 2.2 4区 医学 Q3 RESPIRATORY SYSTEM
Yanran Duan, Hang Fu, Changying Chen, Yaojun Zhao, Shuai Jiang, Chengzeng Wang
{"title":"Comorbidity Patterns in Chronic Obstructive Pulmonary Disease and Their Associations with Service Utilization.","authors":"Yanran Duan, Hang Fu, Changying Chen, Yaojun Zhao, Shuai Jiang, Chengzeng Wang","doi":"10.1080/15412555.2024.2414793","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence of combinations of comorbidities and their associations with inpatient service utilization and readmission among patients with chronic obstructive pulmonary disease (COPD) have not been extensively examined. To address this gap in knowledge, an observational prospective study was conducted using retrospective data.</p><p><strong>Aims: </strong>To identify patterns of comorbidities linked to length of hospital stay, daily expenses, and one-year readmission.</p><p><strong>Methods: </strong>The 30 most common comorbidities were identified in patients with secondary diagnoses using the association rule mining (ARM) method. Regression models were used to examine the relationships between combinations of comorbidities and service utilization, with adjustments for covariates.</p><p><strong>Results: </strong>The five most prevalent comorbidities were pulmonary heart disease (40.99%), ischemic heart disease (38.97%), heart failure (36.77%), hypertension (34.11%), and respiratory disorders (19.12%). Most combinations of comorbidities identified by ARM showed significant associations with an extended length of stay (>13 days), increased daily expenses (>930 CNY), and reduced readmission rates. Among these combinations, glycoprotein metabolism disorder had the strongest association with prolonged length of stay (adjusted odds ratio [aOR]): 1.89, 95% confidence interval [CI]: 1.82-1.95). Conversely, the combination of other brain diseases and respiratory failure was linked to higher daily expenses (aOR: 11.34, 95% CI: 10.58-12.15), and the presence of pulmonary heart disease was associated with elevated one-year readmission rates (aOR: 1.41, 95% CI: 1.37-1.46).</p><p><strong>Conclusion: </strong>Common combinations of comorbidities among inpatients with COPD were identified from an extensive collection of discharge medical records. Furthermore, the associations between comorbidities, inpatient service usage, and readmission rates were determined.</p>","PeriodicalId":10704,"journal":{"name":"COPD: Journal of Chronic Obstructive Pulmonary Disease","volume":"21 1","pages":"2414793"},"PeriodicalIF":2.2000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"COPD: Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15412555.2024.2414793","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The prevalence of combinations of comorbidities and their associations with inpatient service utilization and readmission among patients with chronic obstructive pulmonary disease (COPD) have not been extensively examined. To address this gap in knowledge, an observational prospective study was conducted using retrospective data.

Aims: To identify patterns of comorbidities linked to length of hospital stay, daily expenses, and one-year readmission.

Methods: The 30 most common comorbidities were identified in patients with secondary diagnoses using the association rule mining (ARM) method. Regression models were used to examine the relationships between combinations of comorbidities and service utilization, with adjustments for covariates.

Results: The five most prevalent comorbidities were pulmonary heart disease (40.99%), ischemic heart disease (38.97%), heart failure (36.77%), hypertension (34.11%), and respiratory disorders (19.12%). Most combinations of comorbidities identified by ARM showed significant associations with an extended length of stay (>13 days), increased daily expenses (>930 CNY), and reduced readmission rates. Among these combinations, glycoprotein metabolism disorder had the strongest association with prolonged length of stay (adjusted odds ratio [aOR]): 1.89, 95% confidence interval [CI]: 1.82-1.95). Conversely, the combination of other brain diseases and respiratory failure was linked to higher daily expenses (aOR: 11.34, 95% CI: 10.58-12.15), and the presence of pulmonary heart disease was associated with elevated one-year readmission rates (aOR: 1.41, 95% CI: 1.37-1.46).

Conclusion: Common combinations of comorbidities among inpatients with COPD were identified from an extensive collection of discharge medical records. Furthermore, the associations between comorbidities, inpatient service usage, and readmission rates were determined.

慢性阻塞性肺病的并发症模式及其与服务利用的关系。
背景:慢性阻塞性肺病(COPD)患者的合并症发生率及其与住院服务使用和再入院的关系尚未得到广泛研究。为了填补这一知识空白,我们利用回顾性数据开展了一项前瞻性观察研究。目的:确定与住院时间、每日费用和一年再入院相关的合并症模式:方法:使用关联规则挖掘(ARM)方法,在有二次诊断的患者中识别出 30 种最常见的合并症。使用回归模型研究合并症组合与服务利用率之间的关系,并对协变量进行调整:最常见的五种合并症是肺心病(40.99%)、缺血性心脏病(38.97%)、心力衰竭(36.77%)、高血压(34.11%)和呼吸系统疾病(19.12%)。ARM 发现的大多数合并症组合与住院时间延长(>13 天)、每日费用增加(>930 元人民币)和再入院率降低有显著关联。在这些合并症中,糖蛋白代谢紊乱与住院时间延长的关系最为密切(调整赔率[aOR]):1.89,95% 置信区间 [CI]:1.82-1.95):1.82-1.95).相反,其他脑部疾病和呼吸衰竭的合并症与较高的日常开支有关(aOR:11.34,95% CI:10.58-12.15),肺心病的存在与较高的一年再入院率有关(aOR:1.41,95% CI:1.37-1.46):结论:从大量出院病历中发现了慢性阻塞性肺病住院患者常见的合并症组合。此外,还确定了合并症、住院服务使用情况和再入院率之间的关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
38
审稿时长
6-12 weeks
期刊介绍: From pathophysiology and cell biology to pharmacology and psychosocial impact, COPD: Journal Of Chronic Obstructive Pulmonary Disease publishes a wide range of original research, reviews, case studies, and conference proceedings to promote advances in the pathophysiology, diagnosis, management, and control of lung and airway disease and inflammation - providing a unique forum for the discussion, design, and evaluation of more efficient and effective strategies in patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信